C. de Mey, M. Althaus, E. Ezan, A. Retzow: Erythromycin increases plasma concentrations of alpha-dihydroergocryptine in humans. In: Clin Pharmacol Ther. 70, 2001, S. 142–148. PMID 11503008
L. Battistin, P. G. Bardin, F. Ferro-Milone u. a.: Alpha-dihydroergocryptine in Parkinson's disease: a multicentre randomized double blind parallel group study. In: Acta Neurol Scand. 99, 1999, S. 36–42. PMID 9925236
B. Bergamasco, L. Frattola, A. Muratorio u. a.: Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients: results of a multicentre, randomized, double-blind, placebo-controlled study. In: Acta Neurol Scand. 101, 2000, S. 372–380. PMID 10877152
G. Bussone, R. Cerbo, N. Martucci u. a.: Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizine. In: Headache. 39, 1999, S. 426–431. PMID 11279920
G. Micieli, A. Cavallini, S. Marcheselli u. a.: Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis. In: Int J Clin Pharmacol Ther. 39, 2001, S. 144–151. PMID 11332869
F. Tergau, S. Wischer, C. Wolf, W. Paulus: Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine. In: Mov Disord. 16, 2001, S. 731–735. PMID 11481700.
